From: Therapeutic potential of heterocyclic pyrimidine scaffolds
Compounds | Volume of edema (ml)a | ||
---|---|---|---|
0 | 1st day | 8th day | |
e5 | 0.31 ± 0.01 | 0.51 ± 0.03b (44)c | 0.68 ± 0.02b (31) |
e6 | 0.35 ± 0.02 | 0.54 ± 0.01b (47) | 0.67 ± 0.02b (40) |
e7 | 0.33 ± 0.02 | 0.15 ± 0.01b (50) | 0.67 ± 0.02b (37) |
Control | 0.32 ± 0.01 | 0.68 ± 0.01 | 0.86 ± 0.03 |
Diclofenac | 0.32 ± 0.02 | 0.52 ± 0.02b (44) | 0.64 ± 0.02b (40) |